Peptide shots are injectable medications made from short chains of amino acids, the same building blocks that form proteins in your body. They’re designed to mimic or enhance specific biological signals, triggering responses like fat burning, tissue repair, or growth hormone release. Some peptide shots, like those used for weight loss, are FDA-approved prescription medications. Others, particularly those marketed for injury recovery or anti-aging, exist in a grayer regulatory space and are obtained through compounding pharmacies or wellness clinics.
How Peptide Shots Work
Your body already produces thousands of peptides naturally. They act as chemical messengers, telling cells what to do: build collagen, release hormones, grow new blood vessels, regulate appetite. Peptide shots introduce synthetic or modified versions of these messengers, often at higher concentrations than your body would produce on its own, to amplify a specific process.
Most peptide shots are given subcutaneously, meaning the needle goes just under the skin rather than into muscle or a vein. Common injection sites include the abdomen, outer thigh, upper arm, and buttocks. The needles are small, typically 4 to 6 millimeters long and 30 to 32 gauge (about the same size used for insulin), so the injections are relatively painless. Depending on the peptide, you might inject daily, a few times per week, or weekly.
Weight Loss Peptides
The most widely prescribed peptide shots right now target weight loss. These include semaglutide (sold as Wegovy and Ozempic) and tirzepatide (Mounjaro, Zepbound). Both work by mimicking a gut hormone called GLP-1 that signals fullness to your brain and slows stomach emptying, so you feel satisfied with less food.
The clinical results are substantial. In the STEP-1 trial, semaglutide led to an average weight loss of 14.9% of body weight over 68 weeks. Tirzepatide goes further: the SURMOUNT-1 trial showed 20.9% weight loss at 72 weeks at the highest dose, with some participants losing up to 22.5%. For someone weighing 250 pounds, that translates to roughly 37 to 56 pounds. These are weekly injections, and the dose is gradually increased over several weeks to reduce side effects. Nausea is the most common complaint, especially early on, along with occasional vomiting and digestive discomfort.
Tirzepatide activates two receptors instead of one, which likely explains the greater weight loss. Both medications are FDA-approved for chronic weight management in people with obesity or overweight with at least one weight-related health condition.
Growth Hormone Peptides
Another popular category includes peptides that stimulate your pituitary gland to produce more growth hormone. The two most commonly paired are CJC-1295 and ipamorelin. CJC-1295 is a modified version of the hormone that tells your pituitary to release growth hormone, but it’s been engineered to last much longer in the body. In clinical trials, a single dose kept growth hormone and its downstream signals elevated for up to 28 days. Ipamorelin works through a different receptor on the same gland, and the two are often combined for a stronger, more sustained effect.
People use these peptides hoping for improved body composition (more muscle, less fat), better sleep, faster recovery from workouts, and a general sense of vitality. These peptides are not FDA-approved for anti-aging or fitness purposes. They’re available through compounding pharmacies, often prescribed by anti-aging or functional medicine clinics, and the evidence supporting their use for these goals comes mostly from small studies and clinical observation rather than large trials.
Tissue Repair Peptides
BPC-157 and TB-500 are two peptides commonly sought out for injury recovery, particularly for tendons, ligaments, and joints. BPC-157 is a fragment of a protein naturally found in gastric juice. In laboratory and animal studies, it promotes healing through several pathways: it stimulates the growth of new blood vessels by activating signaling that increases blood flow to damaged tissue, and it accelerates tendon and ligament repair by boosting the activity of fibroblasts, the cells responsible for producing collagen.
The animal research is genuinely promising. BPC-157 has shown benefits for Achilles tendon tears, muscle injuries, and even gut lining repair in rodent models. The catch is that there are no completed large-scale human clinical trials. The FDA has not approved BPC-157 for any medical use. Its regulatory future remains uncertain: the FDA removed it from a list of substances flagged for significant safety risks after nominations were withdrawn, and the agency plans to consult its Pharmacy Compounding Advisory Committee in July 2026 about whether BPC-157 can be included on the approved list for compounding. For now, availability depends on your state’s compounding laws and your prescriber’s willingness to order it.
Skin and Collagen Peptides
GHK-Cu is a copper-binding peptide that your body produces naturally, though levels decline significantly with age. It stimulates the production of collagen, elastin, and glycosaminoglycans (the molecules that keep skin hydrated and plump), and it supports the growth of new blood vessels and nerve tissue. In one study, GHK-Cu applied to thigh skin for 12 weeks improved collagen production in 70% of women treated, outperforming both vitamin C cream (50%) and retinoic acid (40%).
While GHK-Cu is more commonly found in topical serums, injectable versions are available through compounding pharmacies and are marketed for more systemic anti-aging effects. Lab research shows it activates fibroblasts at extremely low concentrations, increasing both elastin and collagen output. The injectable form is far less studied than the topical, and most of the robust data comes from cell culture and skin application studies rather than injection trials.
Side Effects and Risks
Side effects vary widely depending on the peptide. For GLP-1 weight loss shots, nausea, vomiting, and digestive issues are common, especially during the dose-escalation phase, and they typically improve over time. Injection site reactions like redness, swelling, or itching can happen with any subcutaneous shot.
The risks become harder to quantify with peptides that lack robust human trial data. Misuse or overuse of growth hormone-stimulating peptides can cause joint pain, fluid retention, headaches, and numbness or tingling. More serious consequences documented with peptide hormone abuse include elevated blood sugar, thyroid dysfunction, and increased cardiovascular risk. The quality of the product itself is another variable. Peptides from compounding pharmacies are not held to the same manufacturing standards as FDA-approved drugs, so potency and purity can vary between sources.
Storage and Preparation
Most peptide shots arrive as a freeze-dried powder in a small vial. You reconstitute them by injecting sterile water (usually bacteriostatic water, which contains a small amount of preservative) into the vial and gently swirling until the powder dissolves. You never shake a peptide vial, as this can damage the molecular structure.
Storage matters more than most people realize. Unreconstituted powder should be kept at minus 20°C (a standard freezer) for short-term storage of one to two weeks, and minus 80°C for anything longer. Exposure to moisture degrades the peptide even before you open the vial. Once reconstituted, the solution should be refrigerated and used within a set timeframe, typically two to four weeks depending on the peptide. If you need to store reconstituted peptide longer, divide it into single-use portions and freeze them separately to avoid repeated freeze-thaw cycles, which break down the active compound.
Legal and Regulatory Status
The regulatory landscape for peptide shots is split. GLP-1 agonists like semaglutide and tirzepatide are fully FDA-approved, widely studied, and available through standard prescriptions. Growth hormone itself is FDA-approved but only for specific diagnoses like growth hormone deficiency, not for anti-aging or athletic performance.
Many other peptides, including BPC-157, CJC-1295, and ipamorelin, occupy a regulatory middle ground. They can be prepared by compounding pharmacies under Sections 503A and 503B of federal law, which allow pharmacies to create custom medications not commercially available. This is legal, but it means these peptides have not gone through the full FDA approval process. They haven’t been evaluated for safety and efficacy in the way that approved drugs have. The quality and consistency of compounded products depend heavily on the pharmacy producing them, so sourcing from an accredited compounding pharmacy (look for PCAB accreditation) reduces but does not eliminate risk.